Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126563361 | 12656336 | 1 | I | 201508 | 20150806 | 20160816 | 20160816 | PER | US-PERRIGO-15US008166 | PERRIGO | 0.00 | M | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126563361 | 12656336 | 1 | PS | LORATADINE. | LORATADINE | 1 | Oral | UNK | U | U | 4K2996 | 76301 | TABLET | ||||||
| 126563361 | 12656336 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | UNK | U | U | UNKNOWN | 0 | |||||||
| 126563361 | 12656336 | 3 | C | ANTIHYPERTENSIVES | UNSPECIFIED INGREDIENT | 1 | Unknown | UNK | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126563361 | 12656336 | 1 | Product used for unknown indication |
| 126563361 | 12656336 | 2 | Anxiety |
| 126563361 | 12656336 | 3 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126563361 | 12656336 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126563361 | 12656336 | 1 | 201508 | 0 |